Extended treatment with bupropion SR for cigarette smoking cessation

Journal of Consulting and Clinical Psychology
Joel D KillenAlan F Schatzberg

Abstract

The authors present results of a randomized clinical trial of the efficacy of extended treatment with bupropion SR in producing longer term cigarette smoking cessation. Adult smokers (N = 362) received open-label treatment (11 weeks) that combined relapse prevention training, bupropion SR, and nicotine patch followed by extended treatment (14 weeks) with bupropion SR or matching placebo. Abstinence percentages were relatively high (week 11: 52%; week 25: bupropion, 42%; placebo, 38%; week 52: bupropion, 33%; placebo, 34%), but bupropion SR did not surpass placebo. Gender and baseline craving level were identified as significant, independent moderators of treatment response. Men were more likely to abstain than women (week 11: 59% vs. 43%, p = .001; week 25: 48% vs. 31%, p = .001; week 52: 39% vs. 27%, p = .01). Because most smokers suffer relapse with any current cessation treatment, the comparatively high abstinence percentages achieved in this trial are of interest.

References

Dec 1, 1991·Archives of General Psychiatry·N BreslauP Andreski
Apr 1, 1991·Archives of General Psychiatry·J B GreenhouseR F Prien
Sep 26, 1990·JAMA : the Journal of the American Medical Association·R F AndaP L Remington
Sep 16, 1988·JAMA : the Journal of the American Medical Association·J D KillenB Newman
Apr 1, 1987·British Journal of Addiction·R West, N Schneider
Jan 1, 1984·Psychopharmacology·N G Schneider, M E Jarvik
Nov 1, 1995·JAMA : the Journal of the American Medical Association·L C DaleD R Schroeder
Jan 27, 1996·Lancet·C P O'Brien, A T McLellan
Jul 1, 1996·Addictive Behaviors·G E SwanL M Jack
Oct 23, 1997·The New England Journal of Medicine·R D HurtP M Sullivan
Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Aug 18, 1999·Journal of Consulting and Clinical Psychology·D W WetterT B Baker
Feb 9, 2000·Psychopharmacology·S ShiffmanJ DeVeaugh-Geiss
Jun 27, 2001·Circulation·L A Moyé
May 23, 2002·Clinical Therapeutics·Michael J DurcanDavid P L Sachs
Oct 9, 2002·Archives of General Psychiatry·Sharon M HallRoland Maude-Griffin
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard D HurtPhilip J Stella
Jun 5, 2003·The Journal of Otolaryngology·Chetan GujrathiSylvia Asa
Jan 16, 2004·Trends in Pharmacological Sciences·Tony P George, Stephanie S O'Malley
Oct 30, 2004·The American Journal of Psychiatry·Sharon M HallJennifer Cullen

❮ Previous
Next ❯

Citations

Jun 30, 2010·Psychopharmacology·Robert F LeemanSherry A McKee
Jul 1, 2008·Journal of General Internal Medicine·Janet L ThomasJasjit S Ahluwalia
Jun 16, 2010·Experimental and Clinical Psychopharmacology·Stephen J HeishmanEdward G Singleton
Mar 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adriana LoriJoseph F Cubells
Mar 19, 2008·The Pharmacogenomics Journal·D F HeitjanC Lerman
Apr 18, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Stephen J HeishmanWallace B Pickworth
May 29, 2007·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Robert F LeemanStephanie S O'Malley
Jan 28, 2012·Journal of the National Cancer Institute·Lisa Sanderson CoxJasjit S Ahluwalia
Mar 26, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Ivan BerlinStephen J Heishman
Mar 1, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Taneisha S BuchananNicole L Nollen
Jan 8, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jennifer M WrayStephen T Tiffany
Apr 3, 2007·Journal of Periodontology·Getúlio da R Nogueira-FilhoUrbino da R Tunes
Oct 17, 2007·Journal of Women's Health·Robert A SchnollCaryn Lerman
Jun 10, 2011·American Journal of Public Health·Sharon M HallJulie A Robbins
Aug 31, 2006·Expert Opinion on Emerging Drugs·Robert A Schnoll, Caryn Lerman
Jan 15, 2013·Journal of Substance Abuse Treatment·Paolo IlicetoDomenico Enea
Aug 9, 2011·Drug Discovery Today·Martin Wehling
Feb 17, 2009·Drug and Alcohol Dependence·Stephen J HeishmanDavid A Gorelick
Jan 13, 2009·Drug and Alcohol Dependence·Robert A Schnoll, Freda Patterson
Mar 6, 2007·Addictive Behaviors·Dustin C LeeStephen J Heishman
Apr 28, 2009·Addiction·Sharon M HallJudith J Prochaska
Jan 27, 2011·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jane E SarginsonGreer M Murphy
Mar 26, 2008·The American Journal of Medicine·J Taylor HaysAmit Sood
Jan 13, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jane E SarginsonGreer M Murphy
Feb 28, 2017·Addiction·Jennifer R LaudeSean P David
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Amanda C FarleyPaul Aveyard
Jan 10, 2014·The Cochrane Database of Systematic Reviews·John R HughesTim Lancaster
Oct 16, 2008·Addiction·Joel D KillenMaya Pandurangi
Aug 22, 2013·The Cochrane Database of Systematic Reviews·Peter HajekTim Lancaster
Feb 14, 2019·The Cochrane Database of Systematic Reviews·Jonathan Livingstone-BanksPeter Hajek
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Jonathan Livingstone-BanksPeter Hajek
Apr 23, 2020·The Cochrane Database of Systematic Reviews·Seth HowesNicola Lindson
Mar 6, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Steffani R BaileyJoel D Killen
Sep 9, 2017·The Cochrane Database of Systematic Reviews·Ewoud SchuitSean P David
Feb 10, 2021·Expert Review of Clinical Pharmacology·Maria Gabriella MateraMario Cazzola
May 9, 2021·Annual Review of Clinical Psychology·Timothy B Baker, Danielle E McCarthy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.